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Information in practice
Virtual outreach: economic evaluation of joint
teleconsultations for patients referred by their general
practitioner for a specialist opinion
P B Jacklin, J A Roberts, P Wallace, A Haines, R Harrison, J A Barber, S G Thompson, L Lewis,
R Currell, S Parker, P Wainwright, for the Virtual Outreach Project Group
Abstract
Objectives To test the hypotheses that, compared with
conventional outpatient consultations, joint
teleconsultation (virtual outreach) would incur no
increased costs to the NHS, reduce costs to patients,
and reduce absences from work by patients and their
carers.
Design Cost consequences study alongside
randomised controlled trial.
Setting Two hospitals in London and Shrewsbury and
29 general practices in inner London and Wales.
Participants 3170 patients identified; 2094 eligible
for inclusion and willing to participate. 1051
randomised to virtual outreach and 1043 to standard
outpatient appointments.
Main outcome measures NHS costs, patient costs,
health status (SF-12), time spent attending index
consultation, patient satisfaction.
Results Overall six months costs were greater for the
virtual outreach consultations (£724 per patient) than
for conventional outpatient appointments (£625):
difference in means £99 ($162; €138) (95%
confidence interval £10 to £187, P=0.03). If the
analysis is restricted to resource items deemed
“attributable” to the index consultation, six month
costs were still greater for virtual outreach: difference
in means £108 (£73 to £142, P < 0.0001). In both
analyses the index consultation accounted for the
excess cost. Savings to patients in terms of costs and
time occurred in both centres: difference in mean
total patient cost £8 (£5 to £10, P < 0.0001). Loss of
productive time was less in the virtual outreach group:
difference in mean cost £11 (£10 to £12, P < 0.0001).
Conclusion The main hypothesis that virtual
outreach would be cost neutral is rejected, but the
hypotheses that costs to patients and losses in
productivity would be lower are supported.
Introduction
Between 6% and 10% of contacts between patients and
primary care result in a referral for a specialist opinion.1
The efficacy of this process depends on effective
communication across the primary-secondary care
interface, which may be lacking in practice.2–4 The
current referral practice can result in unnecessary follow
up of patients and a duplication of tests and
investigations, leading to dissatisfaction among patients
and clinicians.5–7 Studies in the Netherlands have shown
that involvement of general practitioners in joint consul-
tations can lead to better patient management,
reductions in hospital follow up appointments, fewer
tests and investigations, improvements in health status
one year after referral, and fewer subsequent referrals to
hospital.8 9 However, consultations that require all
participants to be in the same place are difficult to
organise and costly. A videoconferencing link avoids the
need for physical proximity, while potentially offering
the same benefits in communication.
The NHS information technology strategy pre-
dicted an important role for telemedicine in the future
provision of healthcare services.10 The clinical reliabil-
ity of the technology has been established.11 A recent
systematic review commented on the poor quality of
studies on the economic effectiveness of telemedicine
and found no evidence that telemedicine was cost
effective.12 Very little has been published on the cost
effectiveness of teleconsultation—“real time” consulta-
tions in which doctors and patients are separated geo-
graphically but communicate through the use of
videoconferencing.13 The economic evaluation of the
virtual outreach project, the largest reported ran-
domised trial of teleconsultations, thus provides
important new information.
Methods
The design of the trial, details of the method, and other
outcomes have been described in full elsewhere.14 15
The investigators established virtual outreach services
in the Royal Free Hampstead NHS Trust in inner
London and the Royal Shrewsbury Hospital Trust in
Shropshire. Virtual outreach involved a “real time”
joint consultation between the general practitioner,
present with the patient in the practice, and consultants
in the hospital. The general practitioners referred a
total of 3170 patients, of whom 2094 consented to par-
ticipate in the study and were eligible for inclusion—
862 in Shrewsbury and 1232 in London. The
investigators randomised 1051 patients to the virtual
outreach group and 1043 to standard outpatient
Members of the
project group and
participating
professionals
appear on bmj.com
Department of
Public Health
Policy, London
School of Hygiene
and Tropical
Medicine, London
WC1 7HT
P B Jacklin
research fellow (health
economics)
J A Roberts
professor of economics
of public health
Dean’s Office,
London School of
Hygiene and
Tropical Medicine
A Haines
professor of public
health and primary
care
Department of
Primary Care and
Population
Sciences, Royal Free
and University
College Medical
School, London
NW3 2PF
P Wallace
professor of primary
care
R Harrison
senior research fellow
(telemedicine)
S Parker
research nurse
continued over
bmj.com 2003;327:84
page 1 of 8BMJ VOLUME 327 12 JULY 2003 bmj.com
appointments; they followed participants for six
months after their index consultation.
We adopted a cost consequence approach for this
study, as it involved an array of health outcome meas-
ures alongside costs.16 17 Although the perspective of
the evaluation embraces the patient in addition to the
NHS, it falls short of the societal approach involved in
a full cost benefit study. The hypotheses of the
economic evaluation were that, compared with
conventional outpatients, virtual outreach would incur
no increased costs to the NHS; reduce the costs
incurred by patients attending outpatient appoint-
ments; and reduce the time taken off work, so having a
positive impact on productivity.
Costs to the NHS
The economic evaluation focused on actual resources
used. We derived a cost for each patient for the index
consultation and the six month follow up period.
Index consultation
We costed the consultations to which patients were
randomised by using an “ingredients” approach.16 The
main ingredients were capital and overhead costs, pro-
fessionals’ time, and telephone line costs. We estimated
professionals’ time by using observation by non-
participants of a small sample of consultations selected
opportunistically, because of the logistical problems of
scheduling observations and the substantial research
time involved. Joint teleconsultations were observed at
the general practice and hospital clinic in order to esti-
mate the time input of the two clinicians. Table 1 gives
the complete record for the timing of index
consultations. Table 2 summarises the ingredients’
costs for each type of consultation. We used sensitivity
analysis to explore the implications of errors resulting
from these estimates.
The cost of general practitioners’ time, based on
data compiled by Netten and Curtis,18 was £1.96
($3.22; €2.73) a minute, including practice overheads
and training costs. We estimated the cost of a minute of
consultants’ time as £2.90. To ensure comparability
between general practitioner and consultant costs, we
derived the cost of consultants’ time by adding nursing
and clinic costs supplied by the Royal Free Hampstead
NHS Trust to Netten’s figure of £1.82, which includes
an allocation for secretarial support but not the
overheads associated with running an outpatient clinic.
We estimated the costs of telephone calls for the
consultation according to the duration of the triadic
consultation. We assumed that the small training costs
could be absorbed in the costs of clinicians’ time, which
includes a component for training costs. We consid-
ered administrative functions undertaken by the
research team to be artefacts of the trial design and not
a cost of delivering the service.
In addition to the normal overheads incorporated
into the labour costs of general practitioners and con-
sultants, new overheads are incurred by virtual
outreach. We assigned these costs, which included
rental of an ISDN line and installation of software, to
individual consultations by dividing the total cost by
the number of teleconsultations. We calculated the
equivalent annual costs of videoconferencing equip-
ment and accessories over the expected lifetime of the
asset with an interest rate of 6%.19 20 We assumed a life-
time of five years for the videoconferencing equipment
and 20 years for cabinets and trolleys. A total of 889
teleconsultations took place in the virtual outreach
project over 21 months—approximately 500 telecon-
sultations per year.We therefore divided the equivalent
annual cost by 500 to derive a capital cost per consul-
tation. The number of consultations is a key variable in
assigning fixed capital and overhead costs (which do
not vary with output) to an individual consultation, so
the average cost is to some extent a volume artefact. To
take this into account, we report the costs for a single
consultation with and without the fixed cost compo-
nent. In total, 225 patients did not attend their index
consultation, but as most of them gave notice of this we
have assumed that the NHS incurred minimal costs.
We investigated the effects of relaxing this assumption
in the sensitivity analysis.
Prescription data
We collected prescription data and costs electronically
from the computerised record systems of general prac-
tices using EMIS v.5 software and from one practice
using Torex Premiere. We excluded patients from
practices using different computerised systems, as we
were unable to export cost data electronically. These
patients were evenly distributed across the two arms of
the trial (153 in the virtual outreach group and 150 in
the standard outpatient group). We collected prescrip-
tion data for patients in the six months either side of
the index consultation. We deemed a prescription
issued after the index consultation to be “attributable”
to the index consultation if the patient did not receive
the same named prescription for the six months before
the index consultation. A non-clinician carried out the
attribution, and a clinician validated it for one practice.
Table 1 Timings from a sample of consultations
Mean (SD) minutes Range (minutes)
95% confidence
interval
Joint teleconsultation
Duration of consultation (n=31) 10.5 (5.1) 3-22 8.6 to 12.4
Total time: general practitioner (n=14) 26.0 (10.1) 9-45 20.2 to 31.8
Total time: consultant (n=22) 19.9 (8.3) 8-37 16.2 to 23.6
Conventional outpatient appointment
Duration of consultation (n=35) 9.3 (5.2) 3-25 7.5 to 11.0
Total time: consultant (n=35) 11.8 (6.2) 5-27 9.7 to 13.9
Table 2 Cost of an index consultation
Virtual outreach (£) Standard outpatients (£)
Labour:
General practitioner 50.96 NA
Consultant 57.71 34.22
Consumables:
Call charges 0.71 NA
Capital:
Videoconferencing units 23.52 NA
Trolleys 0.12 NA
Cabinets 0.10 NA
Overheads:
ISDN rental 31.50 NA
Software installation 12.37 NA
ISDN installation 15.19 NA
Marginal cost of consultation 109.38 34.22
Average cost of consultation 192.17 34.22
NA=not applicable.
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The two reached agreement on 182/184 items,
indicating that the method was acceptably robust.
Tests, investigations, procedures, and contacts with healthcare
services
Using a standard form and coding system, research
nurses collected data from hospital and practice records
on participants’ use of NHS resources in the six months
after the index consultation. The nurses recorded visits
by patients to the practice to see a doctor, a nurse, or
other clinical practice staff; visits to a patient’s home by
general practitioners or other staff; other contacts with
the practice; visits to outpatients department; inpatient
admissions; accident and emergency department visits;
attendances for day surgery or other inpatient
procedures; any other hospital visits or contacts; and
contacts between hospital consultants and general prac-
titioners. The nurses also collected data on radiological
investigations, blood tests and laboratory investigations,
and other tests and investigations.
We assigned a unit cost to each resource item (table
3). We obtained these from 1999-2000 data from the
Royal Free Hampstead NHS Trust, the Royal
Shrewsbury Hospital Trust, and NHS Reference Costs
2000,21 except for the costs of consultations, which we
derived from Netten and Curtis.18 Much of the use of
resources over the six months was unrelated to the
condition that led to the patient’s recruitment into the
trial. We developed criteria for identifying items of
resource use that could be deemed to be attributable to
the index consultation specialty—for example, a
gastroscopy for a patient referred to a gastroenterolo-
gist. We classified other non-specific items, such as
visits to the general practitioner, blood tests, and labo-
ratory investigations, as attributable if they occurred
within four weeks of the index consultation. We based
all costs to the NHS on actual rather than prescribed
resource use, in order to reflect true clinical practice.
Costs to the patient and impact on productivity
We used a postal questionnaire to collect data on the
costs incurred by patients as a direct result of their
index appointment. We asked patients to record any
travel costs incurred by themselves or anyone
accompanying them and the time taken, including
travel time, to attend the index consultation. We also
collected information about the impact on the paid
work of patients and anyone accompanying them. If
any work time was lost, the questionnaire asked about
whether pay was reduced or whether anyone had taken
annual leave. We estimated productivity losses identi-
fied by using data from the New Earnings Survey.22
Statistical methods
The statistical analysis used for the economic
evaluation followed a prespecified plan based on the
groups as randomised. We used t tests to investigate
differences in costs to the patient and the NHS
between the two arms of the trial.23 Use of
bootstrapping to allow for the skewed distribution of
costs gave very similar results, as expected because the
sample size was large.24 We carried out adjusted analy-
ses by using multiple ordinary least squares regression
with adjustments for site (London or Shrewsbury), spe-
cialty (orthopaedics; urology; ear, nose, and throat; gas-
troenterology; or other), age at randomisation, sex, and
baseline overall score on the Duke severity of illness
inventory.25 In addition, we used tests of interaction to
investigate whether the effect of virtual outreach varied
by site or specialty.
For 21 patients for whom no six months data were
available, we imputed resource use by using the mean
values for patients with data by site and consultation
type. For the 353 patients with missing prescription
data, we imputed mean values by the same method.We
also imputed values for data that were missing from
patient questionnaires—for example, we calculated
costs to patients who reported travel by private car but
Table 3 Use of resources during the six month follow up period, with unit costs
Item
Mean (SD) use of resources
Unit cost or range (£) Source of unit cost*
Virtual outreach
(n=1033)
Standard outpatients
(n=1025)
Primary care services:
General practitioner 2.40 (2.59) 2.27 (2.39) 25 1
Practice nurse 0.73 (1.49) 0.63 (1.32) 9 1
Other clinical staff 0.04 (0.38) 0.06 (0.43) 9 1
Home visits 0.05 (0.30) 0.07 (0.44) 45 1
Other contacts 0.25 (0.68) 0.24 (0.74) 6-20 1, 2
Contacts between hospital and practice 0.24 (0.62) 0.16 (0.49) 19 1, 2
Tests, investigations, and procedures:
Radiological investigations 0.48 (0.95) 0.54 (0.92) 36-580 3, 4
Blood tests and laboratory investigations 2.36 (3.93) 3.01 (4.57) 1.02-236 3, 4
Other tests and investigations 0.39 (0.74) 0.46 (0.77) 2.58-990 3, 4, 5
Hospital services:
Visits to outpatient departments 1.32 (1.57) 1.28 (1.59) 9-127 1, 3, 4, 5
Inpatient admissions 0.11 (0.35) 0.13 (0.39) 76-218/day 3, 4
Accident and emergency 0.06 (0.30) 0.06 (0.28) 112 3
Day surgery and other inpatient procedures 0.11 (0.36) 0.12 (0.38) 29-4956 3, 4, 5
Other hospital visits 0.07 (0.30) 0.12 (0.42) 9-71 3, 4, 5
Other hospital contacts 0.05 (0.26) 0.09 (0.36) 6-18 1, 2
Prescriptions:
No of patients 852 859
Prescriptions 8.72 (12.97) 8.15 (12.53) 0.03-466 6
*Sources of unit costs: 1=Netten and Curtis18; 2=general practitioner estimate; 3=Royal Free Hampstead NHS Trust; 4=Royal Shrewsbury Hospital Trust; 5=NHS
Reference Costs 200021; 6=computerised records at general practices.
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did not specify the actual costs by estimating the
distance of a return trip with www.multimap.com and
imputing a cost on the basis of an average cost of travel
of 20p a mile.26 Where we could not tell whether the
patient had incurred a cost, we imputed a value on the
basis of the mean of all patients with complete data by
site and consultation type.
Sensitivity analysis is used to explore the robust-
ness of results when uncertainty exists about the
assumptions. In this trial, the key uncertainty
concerned the costs of the index consultation. We
therefore did one way sensitivity analysis on the follow-
ing parameters associated with the index consultation:
duration of teleconsultation, duration of conventional
consultation, total general practitioner time, total con-
sultant time, the cost of videoconferencing equipment,
the lifespan of videoconferencing equipment, the cost
of non-attendance, and the number of consultations
per year. In addition, we used a multiway sensitivity
analysis to assess a “best case” scenario for joint
teleconsultations. This involved making optimistic
assumptions about parameter values relating to the
costs of a virtual outreach appointment and pessimistic
assumptions about the duration of a conventional
appointment.
Results
From a total of 3170 eligible patients, the study
included 2094 patients. Of these, 15 later withdrew
their consent. One thousand and fifty one participants
were randomised to virtual outreach consultations and
1043 to standard outpatient appointments. As
reported elsewhere, the randomised groups were well
balanced across sites, by specialty, and by sex, ethnicity,
age, and marital and employment status.14 15
Costs to the NHS
Index consultation—Table 2 gives the costs for the
virtual outreach consultations and standard outpatient
consultations. A total of 225 patients did not attend
their index consultation, 155 in the virtual outreach
group and 70 in the standard outpatient group.
Assuming that the NHS did not incur any costs as a
result of the non-attendance of patients in the trial, the
estimated mean cost of a patient’s index consultation
was £164 in virtual outreach and £32 in standard out-
patients, a difference of £132 (table 4).
Prescription costs—Table 3 and table 4 show the
mean number and cost of all prescriptions issued for
each patient in the six months after the index consulta-
tion. We found no significant differences between the
costs in the two arms of the trial overall, nor by site or
specialty. Basing the analysis on the subset of “attribut-
able” prescriptions also failed to show any significant
differences.
Costs of tests, investigations, and contacts with healthcare
services—We divided the use of NHS resources in the six
months after the index consultation into those
associated with primary care visits and contacts,
secondary care visits and contacts, and tests and proce-
dures (tables 3 and 4). In none of these categories did a
significant difference occur between the two arms of
the trial, and this remained so after adjustment for
baseline characteristics. As reported elsewhere,14 the
number of tests was larger in the standard outpatients
group, and this is reflected in the higher mean costs for
tests and procedures.
Total NHS costs—We estimated the total mean costs
to the NHS as £724 per patient in the virtual outreach
group and £625 per patient in the standard outpatient
group, a difference of £99 (95% confidence interval
£10 to £187, P=0.03) (table 4). Tests of interaction did
not show heterogeneity by site (P=0.17) or specialty
(P=0.19) (fig 1). When we restricted the analysis to
“attributable” resource use (table 4), costs to the NHS
were £393 per patient in the virtual outreach group
and £286 per patient in the standard outpatient group.
The mean difference of £108 (£73 to £142) was similar
Table 4 Summary of costs (£) by sector. Values are means (SDs) unless stated otherwise
Cost Virtual outreach Standard outpatients Difference (95% CI) P value
NHS costs*: (n=1044) (n=1035)
Index consultation† 163.64 31.91 – –
Primary care visits and contacts‡ 75.11 (77.40) 70.41 (72.14) 4.70 (−1.74 to 11.14) 0.15
Secondary care visits and contacts‡ 188.76 (532.28) 208.08 (1068.86) −19.32 (−91.86 to 53.21) 0.60
Tests and procedures‡ 182.21 (403.23) 209.23 (384.31) −27.02 (−60.90 to 6.87) 0.12
Prescription costs§ 114.26 (206.48) 105.63 (173.62) 8.63 (−7.79 to 25.04) 0.30
Total NHS cost (imputed) 723.98 (832.07) 625.26 (1199.77) 98.72 (9.98 to 187.46) 0.03
Adjusted¶ – – 101.79 (15.26 to 188.32) –
Attributable NHS costs (imputed) 393.33 (388.93) 285.75 (406.95) 107.58 (73.35 to 141.82) <0.0001
Adjusted¶ – – 110.50 (76.79 to 144.21) –
Patient costs**: (n=777) (n=820)
Transport costs†† 1.12 (3.06) 4.52 (8.18) −3.40 (−4.02 to −2.79) <0.0001
Lost pay‡‡ 2.53 (16.58) 6.46 (32.51) −3.93 (−6.48 to −1.38) 0.003
Childcare costs§§ 0.03 (0.37) 0.40 (3.93) 0.37 (0.09 to 0.64) 0.01
Total patient costs (imputed) 3.69 (16.89) 11.38 (33.85) −7.70 (−10.35 to −5.05) <0.0001
Adjusted¶ – – −7.65 (−10.30 to −5.01) –
*These data exclude 15 patients who withdrew their consent from the study.
†225 patients in the trial did not attend their index consultation: 155 patients in the virtual outreach group and 70 patients in the standard outpatient group. A zero
cost has been assigned to the index consultation for these patients.
‡Values imputed for 21 patients with missing data; imputed value was mean cost for patients with data.
§Values imputed for 368 patients with missing data; imputed value was mean cost for patients with data.
¶Adjusted (by missing indicator method27) for age at randomisation, sex, specialty, site, and score on Duke severity of illness inventory.
**Based on questionnaires obtained from 1597 eligible patients six months after their index consultation.
††Values imputed for 163 patients with missing data.
‡‡Values imputed for 12 patients with missing data.
§§Values imputed for 70 patients with missing data.
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to that obtained for total resource use but was highly
significant (P < 0.001). Adjustment for baseline charac-
teristics did not greatly affect these results. Tests of
interaction suggested that attributable resource use
and costs varied by specialty (P=0.02) but not by site
(P= 0.52). In urology, mean costs per patient were actu-
ally lower in the virtual outreach group, although this
difference was not statistically significant (fig 2). In all
other specialties, however, the mean cost per patient
was significantly higher in the virtual outreach group.
Costs to patients
A total of 1597 (77%) patients returned
questionnaires—777 (74%) in the virtual outreach
group and 820 (79%) in the standard outpatient group
(table 4). One hundred and thirty eight patients
reported that they incurred transport costs but did not
record an amount.However, 742 patients reported that
they incurred no transport costs, including 89 patients
in the Shrewsbury standard outpatients group. Patients
in the virtual outreach group incurred lower transport
costs for the index consultation than those in the
standard outpatients group. The mean difference in
travel cost was £3.40 (P < 0.0001). Mean travel costs
were higher in the Shrewsbury arm of the trial for both
virtual outreach and standard outpatient groups, but
the magnitude of difference between the two arms of
the trial was almost identical for both sites. In addition,
mean childcare costs arising from the index consulta-
tion were £0.37 (P=0.02) lower for virtual outreach
patients (table 4). The mean loss of pay for patients in
the virtual outreach group was £2.53 compared with a
mean of £6.46 in the standard outpatients group, a dif-
ference of £3.93 (P < 0.01). Total patient costs were sig-
nificantly lower in the virtual outreach arm, with a
mean difference of £7.70 (P < 0.0001).
Losses in productivity
On the basis of the time taken to attend the index con-
sultation, potential productivity was greater in the
virtual outreach arm. The mean improvement was
£10.76 (£9.77 to £11.75, P < 0.0001) per patient. We
found little difference by site: the potential productivity
in the virtual outreach group was £10.09 higher in
London and £11.57 higher in Shrewsbury. Fewer
patients in the virtual outreach group (197/772, 26%)
than in the standard outpatient group (266/813, 33%)
took time off work for the index consultation. The dif-
ference between the groups was more marked in
Shrewsbury (87/360 (24%) v 134/369 (36%); differ-
ence 12%) than in London (110/412 (27%) v 132/444
(30%); difference 3%).
Consequences
The results in terms of health outcomes and health
services outcomes have been described elsewhere.14
Contrary to the central hypothesis that fewer follow up
appointments would be needed in the virtual outreach
group, a significantly greater proportion of patients in
the virtual outreach group were offered a follow up
appointment (intention to treat analysis, 52% v 41%;
odds ratio 1.52 (1.27 to 1.82), P < 0.0001). The
difference was more marked in Shrewsbury than in
London and in ear, nose, and throat and orthopaedic
specialties than in other specialties. No difference in
health outcomes occurred at six months according to
the physical and psychological scores of the SF-12 and
child health questionnaire. Patient satisfaction,
measured with the Ware specific visit questionnaire,28
was significantly higher in patients who had a virtual
outreach consultation—difference in means 0.33 (0.23
to 0.43), P < 0.0001. In addition, the patient enable-
ment inventory,29 which is used to measure the extent
to which patients feel able to cope after their consulta-
tion, showed no significant differences in immediate
outcomes between the two arms of the trial.
Sensitivity analysis
Table 5 shows the results of the one way sensitivity
analysis, indicating two costs for an index teleconsulta-
tion. In order to reflect the current situation in the
NHS, where a virtual outreach service could now be
offered over existing networks at no additional costs,
the lower value excludes the telecommunication costs
incurred in the trial. Virtual outreach appointments
remained more expensive in all scenarios presented
here. Furthermore, total costs to the NHS (based on
attributable resource use) also remained significantly
higher in the virtual outreach group in all cases. The
magnitude of the difference in costs was particularly
Overall
By site:
   London
   Shrewsbury
By specialty:
   Orthopaedics
   Urology
   Ear, nose, and throat
   Gastroenterology
   Other
Difference in total 
cost to NHS (£)
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expensive than standard
outpatients
Virtual outreach more
expensive than standard
outpatients
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Fig 1 Difference in mean total NHS cost (£) between virtual outreach
and standard outpatients groups (P=0.17 for treatment interaction
with site; P=0.19 for interaction with specialty)
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Fig 2 Difference in mean total attributable NHS cost (£) between virtual outreach and
standard outpatients groups (P=0.52 for treatment interaction with site; P=0.02 for interaction
with specialty)
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sensitive to the duration of the teleconsultation, reflect-
ing the importance of clinicians’ time. The difference in
total attributable NHS costs was least significant if, for
example, we assumed the duration of the teleconsulta-
tion to be very short or general practitioners’ time was
substantially reduced.
Relaxing the assumption that non-attendance at
appointments did not result in any costs being
incurred increased the cost of virtual outreach
appointments relative to conventional ones, because
there was a greater prevalence of non-attendance in
the virtual outreach group. We constructed a “best
case” scenario, which estimated a £23 excess cost for
virtual outreach consultations. For professional time
this involved setting a parameter value based on the
lower quartile of observed teleconsultations. For the
duration of conventional consultations we used Royal
Free Hampstead NHS Trust cost data, which assume a
consultation time of 19 minutes. In addition, this best
case assumed 10 000 consultations a year (as opposed
to 500 in the default calculation) and a total videocon-
ferencing equipment cost of £30 000 (default
£52 500). These values were arbitrary, but we used
them to reflect the fact that equipment costs are falling
and that scope exists to use the equipment more inten-
sively.30 31 Taken together, these best case assumptions
may not be entirely realistic but can provide insights
into how teleconsultation would have to be delivered if
cost differences were to be reduced.
Discussion
Implications for the NHS
The analysis based on total use of NHS resources over
six months shows that overall the mean cost per
patient was significantly higher in the virtual outreach
group than in the standard outpatients group by
almost £100. When we restricted the analysis to attrib-
utable resource data the mean cost per patient was
£108 more in the virtual outreach group. The similar-
ity in the mean difference between the two approaches
suggests that the attributable data excluded a similar
number of resource items from both arms of the trial.
This attributable analysis is likely to reflect the true
position more accurately, because of the “noise” inher-
ent in an analysis based on total resource use.
We based the hypothesis that virtual outreach
would not lead to increased costs to the NHS on the
expectation that better patient management arising
from improved communication would lead to “down-
stream” savings. The results as presented here do not
provide evidence that such savings exist. Although vir-
tual outreach led to a significant reduction in tests and
investigations,14 this resulted in only small downstream
cost savings. The difference in costs was not as marked
as the difference in the number of tests, as the greatest
difference in tests and investigations between the two
groups occurred in low cost routine tests. The real, but
small, cost saving from fewer tests can no longer be
detected when combined with resource use data on
hospital procedures. However, a six month follow up
period may have been too short to enable us to detect
such savings, as these would have to have been large to
compensate for the additional costs of the index
teleconsultation. Furthermore, if the virtual outreach
consultation is of educational value to general
practitioners all patients would benefit through better
overall management, but these potential savings are
not captured by this study.31
The “ingredients” based cost used could overesti-
mate costs for several reasons. Firstly, the average cost
of a virtual outreach consultation is in some respects
an artefact of the trial, as the cost per consultation
depends crucially on the number of consultations.32 We
included the marginal cost of a consultation to take
this into account (table 2). Nevertheless, the sensitivity
analysis showed that at 500 consultations a year the
volume had passed the threshold where important
economies of scale remained available. Secondly, the
technical failures of virtual outreach are likely to be a
function of training, experience, and the state of
technology; they could potentially be reduced, leading
to more efficient use of physicians’ time. Thirdly, ISDN
lines and videoconferencing equipment had to be
installed and purchased specifically for the purposes of
the trial. In future, virtual outreach services would use
existing facilities in the hospital and general practices.
For example, the Digital All Wales Network is now con-
figured to support videoconferencing, with a 256 kilo-
bit link into every practice. NHSnet 2 will offer a similar
service in England. Therefore, only a proportion of
these capital costs would accrue to virtual outreach,
and so the marginal telecommunication costs would be
very low. Finally, the problems of evaluating emerging
telemedicine technology have been well documented.33
By evaluating the teleconsultations at a fixed point in
time, we could not incorporate changes in quality or
price of information technology and telecommunica-
tions equipment. The technology used in the trial was
basic; the price of such equipment might fall, or subse-
quent technology may be more sophisticated and con-
Table 5 One way sensitivity analysis. Times are in minutes unless stated otherwise
Parameter Default Range
Cost of index consultation (£)
Virtual outreach (0) Virtual outreach (1)* Standard outpatient
Consultants’ time: conventional appointment† 11.8 11-19 164 123 30-51
Duration of teleconsultation‡ 10.5 3-22 132-212 92-171 32
General practitioners’ time: teleconsultation‡ 26 10.5-46.5 138-198 97-158 32
Consultants’ time: teleconsultation‡ 19 10.5-30.5 140-190 100-149 32
Videoconferencing equipment (£) £52,000 £10 000-100 000 147-182 107-141 32
Videoconferencing equipment: lifespan 5 years 1-7 years 233-159 193-118 32
No of teleconsultations per year 500 100-10 000 244-144 204-103 32
*As virtual outreach (0) but assumes service can be offered over existing NHS telecommunications network.
†Range based on mean of values observed in non-participant observation and Royal Free Hampstead NHS Trust cost data, which are based on 11 consultations in a
31⁄2 hour outpatient clinic.
‡Includes 10.5 minute consultation; range based on extremes observed in non-participant observation.
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sequently more costly. The trial was pragmatic and
avoided undue constraints on the participating
clinicians, but the introduction of the technique into
routine practice may differ from that in a trial
setting.14 15 This might involve different methods of
scheduling appointments and changes in staffing
arrangements. Economies of scale and scope could
emerge in future service configurations. Systemic
unpredictable changes might be observed if telecon-
sultations become a routine method of delivering out-
patient care.
Implications for patients
Patients attending a teleconsultation incurred signifi-
cantly lower transport costs than did those attending
conventional outpatient appointments, although the
magnitude of the difference (£3) was relatively small.
Our second hypothesis was thus supported. The results
are similar to those obtained in another randomised
controlled trial of telemedicine.31 Although travel costs
may have been underreported, this is unlikely to have
affected the findings materially, and the study also
found that patients in the virtual outreach group lost
significantly less pay. Thus, overall, strong evidence
exists of small financial benefits to patients in attending
virtual outreach consultations.
Patients in the virtual outreach group reported sig-
nificantly shorter time off work than for patients in the
standard outpatient group. However the distribution of
the answers to the questions suggests that some
respondents interpreted the question as referring
solely to travel time. None the less, the trial results pro-
vide good evidence that virtual outreach consultations
are less time consuming for patients and are thus likely
to have a positive impact on productivity. This is also
supported by the results of the patient questionnaire,
showing that the proportion of patients in the virtual
outreach group who reported taking time off work was
lower than that in the standard outpatients group. This
represents further evidence of the potential benefits of
virtual outreach on economic activity, thus supporting
our third hypothesis. Loss of time suggests loss of pro-
ductivity but may not reflect actual loss. Productivity
may be lost forever or may be made up later by the
patient or other workers.
The cost consequences approach is considered a
variant of cost effectiveness analysis,16 but it does not
use the cost effectiveness ratios associated with that
technique. We chose it for this study because the multi-
dimensional character of the outcomes made aggrega-
tion difficult. Firstly, health outcomes were measured
using the SF-12. As described in a previous paper,14 the
physical and psychological scores of the SF-12 at six
months did not differ between the randomised groups.
Such generic health measures are of limited value in
the context of an economic evaluation, because they do
not indicate the value placed on any change in
outcome. A preference based index has been
published for SF-36,34 but mapping algorithms for
SF-12 are still being developed (J E Brazier, personal
communication, 2002). The additional measure used
in the project to assess patient satisfaction indicated
that virtual outreach consultation was associated with
greater levels of satisfaction than standard outpatient
consultation. This is consistent with increased patient
satisfaction reported in other studies of telemedi-
cine.35 36 However, these qualitative measures cannot be
combined to form a single effectiveness measure. A
contingent valuation measure (such as willingness to
pay) might have been used as part of a cost benefit
analysis, but this technique is still in a developmental
stage and would have required additional surveys of
participating patients.
Conclusion
We chose virtual outreach as the trial intervention
because the literature suggested that joint consulta-
tions might improve communications between pri-
mary and secondary care, leading to better patient
outcomes and management. Our prior hypotheses
were that telemedicine would be a cost effective
technology to deliver such joint consultations. How-
ever, the results of this study suggest that this is not so;
the costs of clinicians’ time to support virtual outreach
was large and is unlikely to be offset by subsequent sav-
ings to the NHS in the short term.
Thus little justification on economic grounds
seems to exist for the adoption of virtual outreach.
However, all the benefits may not have been recouped
within the six month follow up period, and we did not
estimate values of improved patient satisfaction. We
may therefore have underestimated the beneficial con-
sequences of virtual outreach. Changes in costs and
technological advances may improve the relative posi-
tion of virtual consultations in future. Furthermore, the
results of the study are a function of how the virtual
outreach project was established. It was a pragmatic
trial with broad inclusion criteria. Previous subanalysis
showed that certain specialties may be more appropri-
ate for virtual outreach than others,14 and improved
selection of patients may also improve the relative cost
effectiveness of virtual outreach. Virtual consultations
might also be delivered more cost effectively along
more conventional lines, without the presence of the
general practitioner. However, further research would
be needed to investigate this, as it is not possible to
extrapolate the outcomes of this study to such a mode
of consultation.
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